Dr. Reddy's Laboratories Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Dr. Reddy's Laboratories hat ein Gesamteigenkapital von ₹309.3B und eine Gesamtverschuldung von ₹43.8B, wodurch sich der Verschuldungsgrad auf 14.2% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ₹466.0B bzw. ₹156.7B. Dr. Reddy's Laboratories Das EBIT des Unternehmens beträgt ₹67.7B, so dass der Zinsdeckungsgrad -227.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ₹63.1B.
Wichtige Informationen
14.2%
Verhältnis von Schulden zu Eigenkapital
₹43.82b
Verschuldung
| Zinsdeckungsgrad | -227.8x |
| Bargeld | ₹63.07b |
| Eigenkapital | ₹309.28b |
| Gesamtverbindlichkeiten | ₹156.67b |
| Gesamtvermögen | ₹465.96b |
Jüngste Berichte zur Finanzlage
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: DRREDDYDie kurzfristigen Aktiva des Unternehmens (₹248.1B) übersteigen seine kurzfristigen Passiva (₹129.3B).
Langfristige Verbindlichkeiten: DRREDDYDie kurzfristigen Vermögenswerte des Unternehmens (₹248.1B) übersteigen seine langfristigen Verbindlichkeiten (₹27.4B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: DRREDDY über mehr Barmittel verfügt als seine Gesamtverschuldung.
Schulden abbauen: DRREDDY Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 19.3% auf 14.2% zurückgegangen.
Schuldendeckung: DRREDDYDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (77.7%).
Zinsdeckung: DRREDDY mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.